Abstract:Postural tachycardia syndrome (POTS) is defined by a heart rate increment of 30 beats/min or more within 10 minutes of standing or head-up tilt in the absence of orthostatic hypotension; the standing heart rate is often 120 beats/min or higher. POTS manifests with symptoms of cerebral hypoperfusion and excessive sympathoexcitation. The pathophysiology of POTS is heterogeneous and includes impaired sympathetically mediated vasoconstriction, excessive sympathetic drive, volume dysregulation, and deconditioning. POTS is frequently included in the differential diagnosis of chronic unexplained symptoms, such as inappropriate sinus tachycardia, chronic fatigue, chronic dizziness, or unexplained spells in otherwise healthy young individuals. Many patients with POTS also report symptoms not attributable to orthostatic intolerance, including those of functional gastrointestinal or bladder disorders, chronic headache, fibromyalgia, and sleep disturbances. In many of these cases, cognitive and behavioral factors, somatic hypervigilance associated with anxiety, depression, and behavioral amplification contribute to symptom chronicity. The aims of evaluation in patients with POTS are to exclude cardiac causes of inappropriate tachycardia; elucidate, if possible, the most likely pathophysiologic basis of postural intolerance; assess for the presence of treatable autonomic neuropathies; exclude endocrine causes of a hyperadrenergic state; evaluate for cardiovascular deconditioning; and determine the contribution of emotional and behavioral factors to the patient's symptoms. Management of POTS includes avoidance of precipitating factors, volume expansion, physical countermaneuvers, exercise training, pharmacotherapy (fludrocortisone, midodrine, β-blockers, and/or pyridostigmine), and behavioral-cognitive therapy. A literature search of PubMed for articles published from January 1, 1990, to June 15, 2012, was performed using the following terms (or combination of terms): POTS; postural tachycardia syndrome, orthostatic; orthostatic; syncope; sympathetic; baroreceptors; vestibulosympathetic; hypovolemia; visceral pain; chronic fatigue; deconditioning; headache; Chiari malformation; Ehlers-Danlos; emotion; amygdala; insula; anterior cingulate; periaqueductal gray; fludrocortisone; midodrine; propranolol; β-adrenergic; and pyridostigmine. Studies were limited to those published in English. Other articles were identified from bibliographies of the retrieved articles.

Increased CRTH2 Expression in Postural Orthostatic Tachycardia Syndrome

Postural tachycardia syndrome: a heterogeneous and multifactorial disorder

Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management

Factors associated with initiation of pharmacological therapy and treatment changes in postural orthostatic tachycardia syndrome

Clinical neurophysiology of postural tachycardia syndrome

Postural Hyperventilation as a Cause of Postural Tachycardia Syndrome: Increased Systemic Vascular Resistance and Decreased Cardiac Output When Upright in All Postural Tachycardia Syndrome Variants

Gastrointestinal symptoms in patients with postural orthostatic tachycardia syndrome in relation to hemodynamic findings and immunological factors

Postural Tachycardia Syndrome in Children and Adolescents: Pathophysiology and Clinical Management

G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome

Reduced Stroke Volume and Brain Perfusion Drive Postural Hyperventilation in Postural Orthostatic Tachycardia Syndrome

Navigating Complexity in Postural Orthostatic Tachycardia Syndrome

Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS)

Heart rate-dependent electrocardiogram abnormalities in patients with postural tachycardia syndrome

The face of postural tachycardia syndrome – insights from a large cross‐sectional online community‐based survey

Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon

Vascular Dysfunction of Postural Tachycardia Syndrome in Children

The Value of Acetylcholine Receptor Antibody in Children with Postural Tachycardia Syndrome

Pediatric Postural Orthostatic Tachycardia Syndrome: from Mechanisms to Individualized Management

Pathogenesis and Individualized Treatment for Postural Tachycardia Syndrome in Children

Evaluation of the relationship between mast cell activation and postural orthostatic tachycardia syndrome in children and adolescents

Clinical Features of Hyperadrenergic Postural Tachycardia Syndrome in Children.